Fiorillo, A., Gallego, J., Casanova-Ferrer, F., Urios, A., Ballester, M., San Miguel, T., . . . Montoliu, C. (2023). Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients.
Citación estilo ChicagoFiorillo, A., et al. Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated With Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients. 2023.
Cita MLAFiorillo, A., et al. Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated With Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients. 2023.
Precaución: Estas citas no son 100% exactas.